Haywood Capital Markets analyst Gianluca Tucci maintained his “Buy” rating on Bragg Gaming Group (Bragg Gaming Group Stock Quote, Chart, News, Analysts, Financials TSX:BRAG) but cut his target price to C$7.50 from C$9.00 in an Aug. 14 research note, citing a softer outlook tied to international market weakness. Tucci said the company’s Q2 2025 results […]

Source

Beacon Securities analyst Russell Stanley noted August 14 that Cresco Labs (Cresco Labs Stock Quote, Chart, News, Analysts, Financials CSE:CL) has completed its previously announced debt refinancing, closing on a five-year, $325-million senior secured term loan paying 12.5%. The analyst maintained his “Buy” rating and $1.75 price target on the stock. The new loan replaces […]

Source

Quipt Home Medical’s (Quipt Home Medical Stock Quote, Chart, News, Analysts, Financials TSX:QIPT) fiscal Q3 2025 results were sequentially stable but slightly lower than last year’s quarterly levels, Leede Financial analyst Douglas Loe said Aug. 12. He maintained a “Buy” rating and US$4.50 target. The Kentucky-based respiratory medical equipment distributor was impacted by the discontinuation […]

Source

Paradigm Capital analyst Daniel Rosenberg maintained his “Buy” rating and raised his 12-month target to $8.00 from $7.75 for WELL Health Technologies (WELL Health Technologies Stock Quote, Chart, News, Analysts, Financials TSXV:WELL). He said in an August 14 research note that the company reported Q2 results ahead of expectations, supported by both organic growth and […]

Source

Organigram (Organigram Global Stock Quote, Chart, News, Analysts, Financials TSX:OGI) reported fiscal Q3 2025 results for the period ended June 30 that were in line with expectations, helped by contributions from the Motif acquisition and strong international sales, Haywood Capital Markets analyst Neal Gilmer said Aug. 13. The analyst maintained a “Buy” rating and $2.50 […]

Source

Electrovaya (Electrovaya Stock Quote, Chart, News, Analysts, Financials NASDAQ:ELVA) delivered strong fiscal Q3 2025 results, its second GAAP-profitable quarter and 10th in a row with positive Adjusted EBITDA, Roth Capital Markets analyst Craig Irwin said Aug. 12. He reiterated a “Buy” rating and $10.00 price target. Management now expects to exceed its $60-million fiscal 2025 […]

Source

Leede Financial analyst Douglas Loe said Aug. 13 that Medexus Pharmaceuticals’ (Medexus Pharmaceuticals Stock Quote, Chart, News, Analysts, Financials TSX:MDP) fiscal Q1 2026 results were sequentially strong on early U.S. sales of its newly approved bone marrow conditioning drug Treosulfan/Grafapex, but softer than most periods between fiscal 2023 and fiscal 2025 due to limited growth […]

Source

Beacon Securities analyst Gabriel Leung noted in an August 12 watchlist update that Hydreight Technologies (Hydreight Technologies Stock Quote, Chart, News, Analysts, Financials TSXV:NURS) provided a corporate update highlighting strong VSDHOne order growth. VSDHOne is the company’s fully compliant, tech-enabled ecosystem that connects prescribers and pharmacies with e-commerce healthcare companies — “Shopify for healthcare.” For […]

Source

Research Capital’s Andre Uddin said August 13 he remains focused on Eupraxia Pharmaceuticals’ (Eupraxia Pharmaceuticals Stock Quote, Chart, News, Analysts, Financials TSX:EPRX) clinical development rather than its financial performance, maintaining a “Speculative Buy” rating and C$12 target. The Victoria, B.C.-based company is developing EP-104IAR for osteoarthritis pain and a new formulation for eosinophilic esophagitis, a […]

Source

National Bank Financial Markets analyst Richard Tse said Aug. 12 that reports of Altus Group (Altus Group Stock Quote, Chart, News, Analysts, Financials TSX:AIF) exploring a potential sale follow inbound acquisition interest, with investment bankers soliciting buyer interest, including from private equity. He said sources noted no deal is guaranteed and the company may continue […]

Source

Haywood Capital Markets analyst Neal Gilmer, in an August 11 report, maintained a “Buy” rating and $19.00 target on Green Thumb Industries (Green Thumb Industries Stock Quote, Chart, News, Analysts, Financials CSE:GTII) after the company posted Q2 results that topped revenue expectations and matched Adjusted EBITDA forecasts. Gilmer noted that Green Thumb’s market diversity and […]

Source

Titanium Transportation Group (Titanium Transportation Group Stock Quote, Chart, News, Analysts, Financials TSX:TTNM) reported second-quarter 2025 results that beat revenue and profitability expectations and showed year-over-year growth, Haywood Capital Markets analyst Gianluca Tucci said August 12. He reiterated a “buy” rating and $3.00 target, recommending investors accumulate shares at current levels. Titanium is an asset-based […]

Source

Bitfarms (Bitfarms Stock Quote, Chart, News, Analysts, Financials TSX:BITF) reported second-quarter 2025 revenue of $77.8-million, up 87% year over year, but below the $84.3-million consensus, ATB Capital Markets analyst Martin Toner said August 12. He maintained an “Outperform” rating and $5.00 target. Mining gross profit, excluding depreciation, was $32.4-million, short of ATB’s $46.2-million estimate, for […]

Source

Plug Power (Plug Power Stock Quote, Chart, News, Analysts, Financials NASDAQ:PLUG) reported second-quarter 2025 revenue of $174.0-million, Adjusted EBITDA of negative $125.5-million, and a loss of $0.20 per share, Roth Capital Markets analyst Craig Irwin said August 12. The results beat Roth’s estimates of $140.0-million, negative $104.0-million, and a loss of $0.15, as well as […]

Source

Cresco Labs (Cresco Labs Stock Quote, Chart, News, Analysts, Financials CSE:CL) is well-positioned to complete its debt refinancing and resume growth initiatives, Beacon Securities analyst Russell Stanley said Aug. 11. He maintained a “Buy” rating and C$1.75 share price target after the company reported second-quarter Adjusted EBITDA that beat the highest street estimate. Stanley said […]

Source

VitalHub (VitalHub Stock Quote, Chart, News, Analysts, Financials TSX:VHI) posted better-than-expected quarterly results, with revenue of $23.9-million and EBITDA of $6.3-million, Beacon Securities analyst Gabriel Leung said in an Aug. 11 report. Leung maintained a “Buy” rating and raised his target price to $15.50 from $15.00. He said Beacon had been modelling $21.8-million in revenue […]

Source

Beacon Securities analyst Russell Stanley kept a “buy” rating and C$14 target on Green Thumb Industries (Green Thumb Industries Stock Quote, Chart, News, Analysts, Financials GTII:CNX) after Q2 results, saying his investment view is largely unchanged. Margins remain under pressure from price compression and should stay below 30 per cent in the near term, but […]

Source

Village Farms (Village Farms International Stock Quote, Chart, News, Analysts, Financials NASDAQ:VFF) posted strong second-quarter results, showing its performance following the privatization of its Texas greenhouse assets, Beacon Securities analyst Doug Cooper said Aug. 11. Cooper maintained a “buy” rating and $4.50 target price. Revenue was $59.9-million, including $44.5-million (C$61.4-million) from Canadian and international cannabis, […]

Source

Desjardins Securities analyst Brent Stadler maintained a “Buy” rating and $58.00 target for Hydro One (Hydro One Stock Quote, Chart, News, Analysts, Financials TSX:H) on August 12, describing it as a “top defensive pick with strong growth outlook” and a “set and forget” investment ahead of the company’s second-quarter results on August 13. As reported […]

Source

In his August 11 Q2 2025 update, Ventum Capital Markets analyst Rob Goff maintained a “Buy” rating on Illumin Holdings (Illumin Holdings Stock Quote, Chart, News, Analysts, Financials TSX:ILLM) while lowering his price target to C$2.75 from C$3.40. “We believe our $2.75 price target speaks to the company’s strategic positioning relative to its peers, as […]

Source